Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 22, 2016

View Archived Issues

Role of SUMOylated SOD2 in alcoholic liver disease and liver cancer

FDA expands indication for FluLaval influenza vaccine

FDA grants fast track designation to Oragenics' AG-013

IBT receives positive recommendation to continue phase II trial of IBP-9414

FDA lifts partial clinical hold on trials evaluating Aduro Biotech's LADD platform

AbbVie discontinues development program under Halozyme collaboration

Intarcia Therapeutics submits NDA for ITCA-650

Janssen Pharmaceutica patents TARPgamma8 inhibitors

WHO announces global health funding for RTS,S malaria vaccine

Janssen R&D Ireland discloses agents for RSV infection

Actelion Pharmaceuticals describes TPHI1 inhibitors

Rosetta Genomics enters research agreement with Sheba Medical Center

FDA approves Darzalex in combination with standard of care for relapsed multiple myeloma

Roche presents HBsAg and HBV DNA production inhibitors

FDA approves Soliqua for type 2 diabetes

FDA lifts partial clinical hold on head and neck cancer trials of durvalumab

Midatech receives payment under Emergex license contract

Pan-Nox inhibitor for diabetic nephropathy

Novo Nordisk's Xultophy wins FDA approval for type 2 diabetes

Sandoz's epoetin alfa biosimilar for renal anemia

Regulus chemically modified oligonucleotide for Alport syndrome

Novel Zika virus vaccine based on the Zika E glycoprotein

Phase I clinical testing of the hookworm vaccine NA-APR-1

License and collaboration between Arrowhead and Amgen closed

Spectrum Pharmaceuticals receives CRL from FDA on Qapzola

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...